TreCeuticals – Skincare Game-Changer with CBD

“TreCeuticals is the first patent-pending professional brand of skincare to combine scientifically proven active ingredients (Retinol, hydroxy acids and antioxidants) with the calming benefits of full-spectrum CBD in an easy-to-use system,” says Erin Dodd, who co-founded the company with Sharon Skarr in 2019. Their goal has been to simplify skincare by creating products that are hardworking, effective and help bring the benefits of numerous products into one.

“Launching a company is hard; launching during a global pandemic is insanity!!” CEO Skarr says, relating, “We’ve faced challenges all along the way, from supply-chain shortages to workforce outages and weather disasters! Those were just the pandemic-related difficulties; we also were and continue to be challenged by advertising restrictions regarding CBD. While it’s definitely our game-changer and what makes TreCeuticals more effective than other brands, it’s still a relatively new ingredient in the marketplace.”

Describing their inspiration for the company, President Dodd recalls, “It was late 2019, we were sipping wine around a fire pit, happily enjoying our retirement years in Scottsdale, Ariz., when we began a conversation that would soon change our lives forever. We were talking about what many women talk about — skincare and the aesthetic movement, what we liked and didn’t like, and the self-esteem that goes along with having glowing skin.”

Noting that each had expertise to bring from their previous careers, Skarr says, “We’re also savvy enough to know we don’t have to be the smartest ones in the room! We continually use our networks and resources to learn from and help guide us along the way.” And she notes they put into practice valuable advice they’d been given to be persistent and learn from their mistakes. “We face each new day with a positive attitude and our core values firmly in place — honesty, integrity and transparency in everything we do,” she says, adding, “Finally, HAVE FUN! Life is just too short to sweat the small stuff!!”

—RaeAnne Marsh

TreCeuticals treceuticals.com

Venture capital (VC) funding in the US took a massive hit in the first quarter (Q1) of 2023 as growing investor cautiousness weighed heavy on the deal-making sentiments. Subsequently, VC deals value year-on-year (YoY) nosedived 50.2% from $72.6 billion in Q1 2022 to $36.1 billion in Q1 2023, reveals GlobalData, a leading data and analytics company. globaldata.com